SUSTAINED-RELEASE NIFEDIPINE FORMULATIONS - MOMENT, MODELING AND SIMULATION AS PHARMACOKINETIC ANALYSIS APPROACH

被引：6
|
作者：
REMUNAN, C
MRHAR, A
PRIMOZIC, S
KARBA, R
VILAJATO, JL
机构：
[1] EDVARD KARDELJ UNIV, FAC NAT SCI & TECHNOL, DEPT PHARM, YU-61000 LJUBLJANA, SLOVENIA
[2] EDVARD KARDELJ UNIV, FAC ELECT & COMP ENGN, YU-61000 LJUBLJANA, SLOVENIA
来源：
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | 1992年 / 18卷 / 02期
关键词：
D O I：
10.3109/03639049209043693
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The bioequivalence of three sustained release nifedipine formulations designed in this laboratory, was assayed in rabbits by comparing their plasma time profiles to a reference (Adalat(R) retard). The analysis of data was performed by using the statistical moments as a measure of drug release. Results show a slowler absorption rate in the experimental formulations than in Adalat(R) retard, and not differences in the absorption extent. The composed one-compartment model, described for humans, showed to be also succesfull for rabbits.
引用
收藏
页码：187 / 202
页数：16
相关论文
共 50 条
  • [1] DISSOLUTION SYSTEM FOR NIFEDIPINE SUSTAINED-RELEASE FORMULATIONS
    CHAUDHARY, RS
    GANGWAL, SS
    GUPTA, VK
    SHAH, YN
    JINDAL, KC
    KHANNA, S
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1993, 19 (15) : 1939 - 1946
  • [2] DISSOLUTION SYSTEM FOR NIFEDIPINE SUSTAINED-RELEASE FORMULATIONS
    CHAUDHARY, RS
    GANGWAL, SS
    GUPTA, VK
    SHAH, YN
    JINDAL, KC
    KHANNA, S
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1994, 20 (07) : 1267 - 1274
  • [3] PHARMACOKINETIC EVALUATION OF SUSTAINED-RELEASE FORMULATIONS OF THEOPHYLLINE BY ANALOG HYBRID SIMULATION
    MRHAR, A
    RUBESSA, F
    KARBA, R
    MONEGHINI, M
    PRIMOSIC, S
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 62 (01) : 15 - 19
  • [4] Bioequivalence of Related GelShieldR○ Sustained-release Formulations of Metformin: A Pooled Pharmacokinetic Analysis
    Krebs-Brown, Axel
    Brand, Kerstin M. G.
    Nogueira Filho, Marco A. F.
    Gaikwad, Sumedh
    Schnaars, Yvonne
    [J]. CLINICAL THERAPEUTICS, 2024, 46 (05) : 389 - 395
  • [5] Optimization of Release Kinetics from Sustained-Release Formulations using Model-Independent Pharmacokinetic Simulation
    Maderuelo, Cristina
    Zarzuelo, Aranzazu
    Lanao, Jose M.
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (08) : 3260 - 3267
  • [6] COMPARATIVE PHARMACOKINETIC EVALUATION OF SUSTAINED-RELEASE THEOPHYLLINE FORMULATIONS IN DOGS AND HUMANS
    HUSSEIN, Z
    BIALER, M
    FRIEDMAN, M
    RAZ, I
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1987, 37 (1-2) : 97 - 102
  • [7] PHARMACOKINETIC STUDY IN STEADY-STATE OF SUSTAINED-RELEASE FORMULATIONS OF THEOPHYLLINE
    PEZOA, R
    GAI, MN
    GUTIERREZ, C
    [J]. ARCHIVOS DE BIOLOGIA Y MEDICINA EXPERIMENTALES, 1987, 20 (02): : R238 - R238
  • [8] PHARMACOKINETIC EVALUATION OF SUSTAINED-RELEASE FORMULATIONS OF ANTIEPILEPTIC DRUGS - CLINICAL IMPLICATIONS
    BIALER, M
    [J]. CLINICAL PHARMACOKINETICS, 1992, 22 (01) : 11 - 21
  • [9] SUSTAINED-RELEASE OF NIFEDIPINE FROM GRANULES
    KOHRI, N
    MORI, KI
    MIYAZAKI, K
    ARITA, T
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (01) : 57 - 61
  • [10] BIOAVAILABILITY OF SUSTAINED-RELEASE PROPRANOLOL FORMULATIONS
    MCAINSH, J
    BABER, NS
    HOLMES, BF
    YOUNG, J
    ELLIS, SH
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 1981, 2 (01) : 39 - 48
12345